Article metrics
PDF
Other content recommended for you
- How to keep high-risk studies ethical: classifying candidate solutions
- The social value of candidate HIV cures: actualism versus possibilism
- When to start paediatric testing of the adult HIV cure research agenda?
- Why cure, why now?
- First-in-human HIV-remission studies: reducing and justifying risk
- Cure research and consent: the Mississippi Baby, Barney Clark, Baby Fae and Martin Delaney
- Early response to adalimumab predicts long-term remission through 5 years of treatment in patients with ankylosing spondylitis
- Haemopoietic stem cell transplantation for genetic disorders
- Sickle cell disease: a neglected chronic disease of increasing global health importance
- Are the risks of treatment to cure a child with severe sickle cell disease too high?